More Related Content
Similar to Bringing Omics Under Control with Syapse Data Platform
Similar to Bringing Omics Under Control with Syapse Data Platform (20)
More from David Parpart, D.C.
More from David Parpart, D.C. (11)
Bringing Omics Under Control with Syapse Data Platform
- 2. Proprietary and Confidential. ©2013 Syapse
About Me
Stanford Phd Dropout (Neuro)
Alzheimer’s Research
Biopharma Clinical & Biz Dev
Founder, Syapse (at Stanford)
Board, SXSW Accelerator
@jonathanhirsch
jon@syapse.com
- 3. Proprietary and Confidential. ©2013 Syapse
Problem
38%
40%
43%
50%
70%
75%
Asthma Drugs Arthritis Drugs Cancer Drugs
Antidepressants Diabetes Drugs Alzheimer’s Drugs
- 7. Proprietary and Confidential. ©2013 Syapse
Single Patient Multi-Omics Profile
Genome Proteome
Transcriptome
Microbiome
Epigenome
Immunome
Metabalome
- 11. Proprietary and Confidential. ©2013 Syapse
Enabling Clinical Omics
“A startup called Syapse is trying to bring the world of
“omics” under control with a new data management platform
based on some of the same general techniques that also
power Facebook’s Graph Search.”
- GigaOM
Syapse software enables the generation and use
of omics profiles at laboratories and healthcare
providers to diagnose and treat patients.
- 13. Proprietary and Confidential. ©2013 Syapse
Syapse Platform
Syapse Platform
(semantic computing)
Omics
Profiles
Phenotype
& EMR Drugs
& Trials
Outcomes
Knowledge
& Rules
- 14. Proprietary and Confidential. ©2013 Syapse
Clinical diagnostics workflow
Curation
Sample Accession
& Processing
Results
Storage
Analytical
Pipeline
Report
Delivery
Outcome
Tracking
Syapse for Labs
Report
Generation
Syapse for Labs
OME
Results Portal
Interfaces to 3rd-party tools